Compare General Dynamics Corporation (GD) vs Invesco Ltd. (IVZ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
General Dynamics Corporation vs Invesco Ltd. — how do they compare? General Dynamics Corporation trades at $368.01 (market cap $98.88B), while Invesco Ltd. trades at $30.79 (market cap $13.43B). The key difference: General Dynamics Corporation is far larger — about 7.4× Invesco Ltd.'s market cap, and Invesco Ltd. pays the higher dividend (2.84%). Which is the better fit depends on your goals.
| GD | IVZ | |
|---|---|---|
Market Cap | $98.88B | $13.43B |
Sector | Industrials | Financials |
52-Week High | $376.88 | $30.30 |
52-Week Low | $297.05 | $16.88 |
Enterprise Value | $105.06B | $23.68B |
Dividend Yield | 1.74% | 2.84% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
General Dynamics (GD) trades at $369.5, down 0.88% on the day, with a bullish technical signal and strong fundamental performance. The company has beaten earnings estimates for three consecutive quarters, with Q1 2026 EPS of $4.10 surpassing the $3.67 expectation. Revenue growth is robust, reaching $52.55B in 2025, while net income margin improved to 8.07%. The stock is supported by a substantial $130.8 billion backlog and a consistent dividend, with the next payment of $1.59 scheduled for August 7, 2026.
The outlook for GD is positive, driven by strong defense spending tailwinds, naval contract dominance, and consistent earnings beats. Investment opportunities include exposure to growing submarine and C5ISR markets. Key risks involve execution on massive backlogs, potential defense budget volatility, and valuation metrics (P/E of 23.01) that are above some industry peers, requiring sustained growth to justify.
Invesco (IVZ) trades at $28.73, up 1.16% on the day, with a bullish technical signal from moving averages and a consensus analyst price target of $30.50. Recent earnings show a mixed track record, with a Q1 2026 miss after two prior beats, while the company maintains strong operating cash flow of $1.53B in 2025 despite a negative net income margin. A dividend of $0.22 per share was declared for H1 2026, payable in June.
The outlook is cautiously optimistic, supported by analyst upgrades and solid cash generation, but profitability challenges and competitive pressures in asset management pose risks. Upside potential exists if the company returns to sustained earnings growth and meets Q2 2026 EPS expectations of $0.66.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About General Dynamics Corporation
General Dynamics is a defense contractor and business jet manufacturer. The firm's segments include aerospace, combat systems, marine, and technologies. The company's aerospace segment creates Gulfstream business jets. Combat system produces land-based combat vehicles, such as the M1 Abrams tank. The marine subsegment creates nuclear-powered submarines, among other things. The technologies segment contains two main units, an IT business that primarily serves the government market and a mission systems business that focuses on products that provide command, control, computers, intelligence, surveillance, and reconnaissance capabilities to the military.
Read more on GD →About Invesco Ltd.
Invesco provides investment-management services to retail (65% of managed assets) and institutional (35%) clients. At the end of August 2022, the firm had $1.416 trillion in assets under management spread among its equity (47% of AUM), balanced (5%), fixed-income (22%), alternative investment (14%), and money market (12%) operations. Passive products account for 32% of Invesco's total AUM, including 56% of the company's equity operations and 13% of its fixed-income platform. Invesco's U.S. retail business is one of the 10 largest nonproprietary fund complexes in the country. The firm also has a meaningful presence outside the U.S., with close to one third of its AUM sourced from Canada (2%), the U.K. (4%), continental Europe (11%), and Asia (15%).
Read more on IVZ →
